Attain Technologies B.V.

Attain Technologies B.V. specializes in hemocytometers and cell counting chambers, which are used primarily for manual blood cell counting in clinical and research settings. Their product line includes both vertical and horizontal chamber designs, with varying micron measurements (such as 10µm, 20µm, 50µm, and 100µm) and multiple chamber configurations (e.g., 2-chamber, 4-chamber, 6-chamber). Specialized variants like Neubauer improved, Thoma, and Post Vasectomy Grid slides are also part of their offerings.

Attain Technologies B.V. is headquartered in the Netherlands. The country’s regulatory framework ensures compliance with EU Medical Device Regulations, which is relevant for the classification and authorization of their devices.

All of Attain Technologies B.V.’s devices fall under Class A classification according to the EU Medical Device Regulation (MDR). This classification applies to low-risk devices, such as hemocytometers and cell counting chambers, which are intended for in vitro diagnostic use without significant health risks. Class A devices typically require less stringent regulatory scrutiny but still must comply with essential safety and performance requirements.

Yes, Attain Technologies B.V.’s devices are registered in the EUDAMED database. EUDAMED is the European Union’s medical device registry, where manufacturers list their products to ensure transparency and traceability under EU regulations. This registration helps healthcare professionals, regulators, and other stakeholders verify the legitimacy and classification of the devices.